New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
07:08 EDTAKRXAkorn price target raised to $33 from $30 at Piper Jaffray
Piper Jaffray raised its price target for Akorn shares to $33 to reflect the company's acquisition of VersaPharm. Piper believes Akorn has one of the most attractive long-term growth profiles in the broader specialty pharma space and it keeps an Overweight rating on the stock.
News For AKRX From The Last 14 Days
Check below for free stories on AKRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
07:10 EDTAKRXAkorn potential KUDCo deal makes strategic sense, says Piper Jaffray
Subscribe for More Information
September 12, 2014
09:00 EDTAKRXNeedham skeptical of potential Akorn deal for Kremers
Subscribe for More Information
September 11, 2014
12:56 EDTAKRXAkorn exploring 'inversion' deal for Belgian drugmaker unit, Reuters says
Subscribe for More Information
12:55 EDTAKRXAkorn pursuing potential inversion deal for UCB unit, Reuters says
Subscribe for More Information
September 4, 2014
08:17 EDTAKRXAkorn price target raised to $40 from $26 at Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use